Online Event
In this webinar, Jeff Coller, PhD, will describe a new therapeutic technique that enhances mRNA translation. This technology has numerous clinical applications and works by binding to mRNA and imp roving translation. The approach offers key benefits: it is disease-modifying, restoring normal protein levels; it is mutation agnostic; it can be tailored to precisely control expression, reducing the risk of overexpression; and lastly, it is applicable across indications and highly versatile. This webinar is